English Deutsch 中文
  • Innovative Solutions
  • Expert Support and Knowledge
  • Reliable Cooperation
Menu Deutsch 中文

Lepu Medical Buys 13% Stake in Australia's Viralytics for $29.6 million

Jan. 5, 2018

Viralytics, an innovator in the field of oncoloytic immunotherapy, has raised $29,633,682 in a placement to Lepu Medical Group, a leading diversified life sciences company in China. The investment is a private placement of 36,138,637 shares at a price of $0.82 each. Following the placement, Lepu Medical will own about 13% of Viralytics shares on issue.